© 2015 Elsevier Ltd. All rights reserved.BACKGROUND: Concerns have been raised about efavirenz reducing the effectiveness of contraceptive implants. We aimed to establish whether pregnancy rates differ between HIV-positive women who use various contracept
Background: Women of reproductive age are at the highest risk of both HIV infection and unintended p...
Background: Female participants in AIDS candidate vaccine clinical trials must agree to use effectiv...
Background: Preventing unwanted pregnancies in Women Living with HIV (WLHIV) is a recognised HIV-pre...
BackgroundPreventing unintended pregnancies is paramount for women living with HIV (WLHIV). Previous...
Abstract Background Preventing unintended pregnancies is paramount for women living with HIV (WLHIV)...
IntroductionContraceptive implants containing etonogestrel and levonorgestrel have emerged as popula...
IntroductionPreventing unintended pregnancies is important among all women, including those living w...
ObjectiveThe objective of this study is to assess whether antiretroviral therapy (ART) may diminish ...
With the advancement of antiretroviral therapy and improved life expectancy, women living with HIV/A...
ObjectiveTo assess whether antiretroviral therapy (ART) may diminish the effectiveness of hormonal c...
WHO recently recommended efavirenz (EFV) use for HIV infection through pregnancy, breastfeeding and ...
Despite risks of HIV transmission to infants born of the HIV positive women, contraceptive use is un...
BackgroundWomen of reproductive age are at the highest risk of both HIV infection and unintended pre...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Background: Enabling women living with HIV to effectively plan whether and when to become pregnant i...
Background: Women of reproductive age are at the highest risk of both HIV infection and unintended p...
Background: Female participants in AIDS candidate vaccine clinical trials must agree to use effectiv...
Background: Preventing unwanted pregnancies in Women Living with HIV (WLHIV) is a recognised HIV-pre...
BackgroundPreventing unintended pregnancies is paramount for women living with HIV (WLHIV). Previous...
Abstract Background Preventing unintended pregnancies is paramount for women living with HIV (WLHIV)...
IntroductionContraceptive implants containing etonogestrel and levonorgestrel have emerged as popula...
IntroductionPreventing unintended pregnancies is important among all women, including those living w...
ObjectiveThe objective of this study is to assess whether antiretroviral therapy (ART) may diminish ...
With the advancement of antiretroviral therapy and improved life expectancy, women living with HIV/A...
ObjectiveTo assess whether antiretroviral therapy (ART) may diminish the effectiveness of hormonal c...
WHO recently recommended efavirenz (EFV) use for HIV infection through pregnancy, breastfeeding and ...
Despite risks of HIV transmission to infants born of the HIV positive women, contraceptive use is un...
BackgroundWomen of reproductive age are at the highest risk of both HIV infection and unintended pre...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Background: Enabling women living with HIV to effectively plan whether and when to become pregnant i...
Background: Women of reproductive age are at the highest risk of both HIV infection and unintended p...
Background: Female participants in AIDS candidate vaccine clinical trials must agree to use effectiv...
Background: Preventing unwanted pregnancies in Women Living with HIV (WLHIV) is a recognised HIV-pre...